Pichler Max, Lautsch Dominik, Adler Claudia, Bögl Karl, Drexel Heinz, Eber Bernd, Fauer Christiane, Föchterle Johannes, Föger Bernhard, Gansch Karin, Grafinger Peter, Lechleitner Monika, Ludvik Bernhard, Maurer Gerald, Mörz Reinhard, Paulweber Bernhard, Pfeiffer Karl Peter, Prager Rudolf, Stark Gerhard, Toplak Hermann, Traindl Otto, Weitgasser Raimund
Paracelsus Medical University, Salzburg, Austria.
Wien Med Wochenschr. 2013 Dec;163(23-24):528-35. doi: 10.1007/s10354-013-0219-z. Epub 2013 Aug 27.
Low density lipoprotein (LDL-C) levels determine the cardiovascular risk. Previous studies indicated an LDL-C target attainment of around 50%, but no Austrian wide analysis on results for the federal states was available. We therefore sought to detect potential differences.
Open-label, non-interventional, longitudinal study, registered: www.clinicaltrials.gov NCT 01381679. In all, 746 statin treated patients not at LDL-C goal received intensified therapy for 12 months. The sample was split into nine subgroups, representing the federal states of Austria.We detected an east-west gradient for baseline LDL-C. Individual target values were achieved by 37.2% (range: 26.1-57.7%). After 12 months, LDL-C < 70 mg/l was achieved by 13.5% (5.9-38.5%). Univariate ANCOVA retrieved significant differences within the states (Upper Austria and Salzburg, p = 0.001 and p = 0.0015, respectively). Furthermore, the capacity of intensified lipid lowering therapy applied in practice was as high as -42% as compared to previous standard therapy (additional LDL-C reduction after switch from baseline therapy in Vorarlberg).
低密度脂蛋白(LDL-C)水平决定心血管风险。先前的研究表明LDL-C目标达成率约为50%,但奥地利全国范围内尚未有针对各联邦州结果的分析。因此,我们试图发现潜在差异。
开放标签、非干预性纵向研究,注册于:www.clinicaltrials.gov NCT 01381679。共有746名未达到LDL-C目标的他汀类药物治疗患者接受了强化治疗12个月。样本被分为九个亚组,分别代表奥地利的各个联邦州。我们检测到基线LDL-C存在东西梯度差异。个体目标值的达成率为37.2%(范围:26.1 - 57.7%)。12个月后,LDL-C < 70 mg/l的达成率为13.5%(5.9 - 38.5%)。单因素协方差分析发现各联邦州之间存在显著差异(上奥地利州和萨尔茨堡州,p分别为0.001和0.0015)。此外,与先前的标准治疗相比,实际应用的强化降脂治疗能力高达-42%(福拉尔贝格州从基线治疗转换后额外的LDL-C降低)。